FDA Inspection
Exelead, Inc.Exelead, Inc. – FDA Inspection, May 15, 2018
Record Details
This FDA Inspection record concerns Exelead, Inc., with an inspection on May 15, 2018, issued by the Detroit District Office, covering human drugs.
- Office
- Detroit District Office
- People
- Bo Chi (Issuing Officer)
- Jazmine N. Brown
- Lakshmi Ran Narasimhan (Issuing Officer)
View Company Profile
ID · 4df01950-6e37-4d7b-94e9-4573b3400bb2
Inspection Facts
- Inspection number
- 1055813
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Exelead, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 4, 2025 | Not classified | Detroit District Office | |
| December 20, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 30, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 10, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 16, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Exelead, Inc.
- FDA Inspection 1287394 - 2025-09-04
- FDA Inspection 1225603 - 2023-12-20
- FDA Inspection 1062147 - 2018-07-30
- FDA Inspection 922118 - 2015-04-10
- FDA Inspection 878732 - 2014-05-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.